326 related articles for article (PubMed ID: 26183969)
1. Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS).
Janmohamed SR; van Oosterhout M; de Laat PC; van Rosmalen J; Madern GC; Oranje AP
J Am Acad Dermatol; 2015 Aug; 73(2):258-63. PubMed ID: 26183969
[TBL] [Abstract][Full Text] [Related]
2. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
3. How should propranolol be initiated for infantile hemangiomas: inpatient versus outpatient?
Patel NJ; Bauman NM
Laryngoscope; 2014 Jun; 124(6):1279-81. PubMed ID: 24347141
[No Abstract] [Full Text] [Related]
4. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas.
Moyakine AV; Herwegen B; van der Vleuten CJM
J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436
[TBL] [Abstract][Full Text] [Related]
5. Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol.
Nieuwenhuis K; de Laat PC; Janmohamed SR; Madern GC; Oranje AP
Pediatr Dermatol; 2013; 30(1):64-70. PubMed ID: 22958179
[TBL] [Abstract][Full Text] [Related]
6. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
Marey HM; Elmazar HF; Mandour SS; Khairy HA
J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):37-42. PubMed ID: 28991344
[TBL] [Abstract][Full Text] [Related]
7. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences].
Léauté-Labrèze C; Taïeb A
Ann Dermatol Venereol; 2008 Dec; 135(12):860-2. PubMed ID: 19084699
[No Abstract] [Full Text] [Related]
9. Blood Pressure Monitoring During the Induction and Maintenance Period of Propranolol Therapy for Complicated Infantile Hemangiomas: A Prospective Study of 109 Infants.
Hengst M; Oelert M; Hoeger PH
Pediatr Dermatol; 2015; 32(6):802-7. PubMed ID: 26391729
[TBL] [Abstract][Full Text] [Related]
10. Preliminary experiences in treating infantile hemangioma with propranolol.
Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
[TBL] [Abstract][Full Text] [Related]
11. Safety profile during initiation of propranolol for treatment of infantile haemangiomas in an ambulatory day-care hospitalization setting.
Fogel I; Ollech A; Zvulunov A; Valdman-Greenshpon Y; Atar Snir V; Friedland R; Lapidoth M; Ben-Amitai D
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):2004-2009. PubMed ID: 29573481
[TBL] [Abstract][Full Text] [Related]
12. Ulcerated nasal infantile haemangioma treated by oral propranolol.
Al Dosari S; Riad H
Dermatol Online J; 2013 May; 19(5):18298. PubMed ID: 24011285
[TBL] [Abstract][Full Text] [Related]
13. Low-dose propranolol for infantile hemangioma of the head and neck: Analysis of 23 consecutive patients.
Ren W; Li S; Gao L; Huang S; Zhang L; Qiang C; Liu C; Zhi K
Pediatr Int; 2017 Feb; 59(2):213-217. PubMed ID: 27473874
[TBL] [Abstract][Full Text] [Related]
14. Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial.
Pope E; Lara-Corrales I; Sibbald C; Liy-Wong C; Kanigsberg N; Drolet B; Ma J
JAMA Pediatr; 2022 Jan; 176(1):34-41. PubMed ID: 34747977
[TBL] [Abstract][Full Text] [Related]
15. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
Kumar MG; Coughlin C; Bayliss SJ
Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Radiological Evaluation of Periocular Infantile Hemangioma Treated With Oral Propranolol: A Case Series.
Ginguerra MA; Saito O; Fernandes JBVD; Castro DS; Matayoshi S
Am J Ophthalmol; 2018 Jan; 185():48-55. PubMed ID: 29103963
[TBL] [Abstract][Full Text] [Related]
17. Combined low-dose oral propranolol and oral prednisolone as first-line treatment in periocular infantile hemangiomas.
Koay AC; Choo MM; Nathan AM; Omar A; Lim CT
J Ocul Pharmacol Ther; 2011 Jun; 27(3):309-11. PubMed ID: 21542771
[TBL] [Abstract][Full Text] [Related]
18. Propranolol treatment of infantile hemangiomas does not negatively affect psychomotor development.
Moyakine AV; Hermans DJ; Fuijkschot J; van der Vleuten CJ
J Am Acad Dermatol; 2015 Aug; 73(2):341-2. PubMed ID: 26183988
[No Abstract] [Full Text] [Related]
19. Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol.
Vassallo P; Forte R; Di Mezza A; Magli A
Am J Ophthalmol; 2013 Jan; 155(1):165-170.e2. PubMed ID: 22967870
[TBL] [Abstract][Full Text] [Related]
20. Review of topical beta blockers as treatment for infantile hemangiomas.
Painter SL; Hildebrand GD
Surv Ophthalmol; 2016; 61(1):51-8. PubMed ID: 26408055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
